BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20233796)

  • 1. In vivo molecular imaging of somatostatin receptors in pancreatic islet cells and neuroendocrine tumors by miniaturized confocal laser-scanning fluorescence microscopy.
    Fottner C; Mettler E; Goetz M; Schirrmacher E; Anlauf M; Strand D; Schirrmacher R; Klöppel G; Delaney P; Schreckenberger M; Galle PR; Neurath MF; Kiesslich R; Weber MM
    Endocrinology; 2010 May; 151(5):2179-88. PubMed ID: 20233796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vivo confocal real-time mini-microscopy in animal models of human inflammatory and neoplastic diseases.
    Goetz M; Fottner C; Schirrmacher E; Delaney P; Gregor S; Schneider C; Strand D; Kanzler S; Memadathil B; Weyand E; Holtmann M; Schirrmacher R; Weber MM; Anlauf M; Klöppel G; Vieth M; Galle PR; Bartenstein P; Neurath MF; Kiesslich R
    Endoscopy; 2007 Apr; 39(4):350-6. PubMed ID: 17427071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
    Kumar U; Sasi R; Suresh S; Patel A; Thangaraju M; Metrakos P; Patel SC; Patel YC
    Diabetes; 1999 Jan; 48(1):77-85. PubMed ID: 9892225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, radiolabeling, and preclinical evaluation of a new octreotide analog for somatostatin receptor-positive tumor scintigraphy.
    De K; Bhowmik A; Behera A; Banerjee I; Ghosh MK; Misra M
    J Pept Sci; 2012 Dec; 18(12):720-30. PubMed ID: 23109400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of somatostatin receptor 2A immunohistochemistry, RT-qPCR, and in vivo PET/CT data in patients with pancreatic neuroendocrine neoplasm.
    Kaemmerer D; Wirtz RM; Fischer EK; Hommann M; Sänger J; Prasad V; Specht E; Baum RP; Schulz S; Lupp A
    Pancreas; 2015 May; 44(4):648-54. PubMed ID: 25872131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPCR somatostatin receptor extracellular loop 2 is a key ectodomain for making subtype-selective antibodies with agonist-like activities in the pancreatic neuroendocrine tumor BON cell line.
    Leu FP; Nandi M
    Pancreas; 2010 Nov; 39(8):1155-66. PubMed ID: 20531241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies.
    Lambertini C; Barzaghi-Rinaudo P; D'Amato L; Schulz S; Nuciforo P; Schmid HA
    Regul Pept; 2013 Nov; 187():35-41. PubMed ID: 24188818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog In Vitro and in Mice Bearing H69 Neuroendocrine Xenografts.
    Santini C; Kuil J; Bunschoten A; Pool S; de Blois E; Ridwan Y; Essers J; Bernsen MR; van Leeuwen FW; de Jong M
    J Nucl Med; 2016 Aug; 57(8):1289-95. PubMed ID: 27127222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and functional significance of somatostatin receptors in malignant melanoma.
    Lum SS; Fletcher WS; O'Dorisio MS; Nance RW; Pommier RF; Caprara M
    World J Surg; 2001 Apr; 25(4):407-12. PubMed ID: 11344389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of a ligand targeting the somatostatin-2 receptor for drug delivery to neuroendocrine cancers.
    Li G; Low PS
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1792-1798. PubMed ID: 25791453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSTR1 and SSTR5 subtypes are the dominant forms of somatostatin receptor in neuroendocrine tumors.
    Pisarek H; Pawlikowski M; Kunert-Radek J; Kubiak R; Winczyk K
    Folia Histochem Cytobiol; 2010 Jan; 48(1):142-7. PubMed ID: 20529830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of somatostatin receptor subtype expression by quantitative PCR and correlation with clinicopathological features in pancreatic endocrine tumors.
    Nakayama Y; Wada R; Yajima N; Hakamada K; Yagihashi S
    Pancreas; 2010 Nov; 39(8):1147-54. PubMed ID: 20717067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SSTR-Mediated Imaging in Breast Cancer: Is There a Role for Radiolabeled Somatostatin Receptor Antagonists?
    Dalm SU; Haeck J; Doeswijk GN; de Blois E; de Jong M; van Deurzen CHM
    J Nucl Med; 2017 Oct; 58(10):1609-1614. PubMed ID: 28450563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of somatostatin receptors using labeled PEGylated octreotide, as an active internalization.
    Abdellatif AAH
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1707-1715. PubMed ID: 31418304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours.
    Virgolini I; Gabriel M; Kroiss A; von Guggenberg E; Prommegger R; Warwitz B; Nilica B; Roig LG; Rodrigues M; Uprimny C
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2072-83. PubMed ID: 27174220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SSTR2-based reporters for assessing gene transfer into non-small cell lung cancer: evaluation using an intrathoracic mouse model.
    Singh SP; Han L; Murali R; Solis L; Roth J; Ji L; Wistuba I; Kundra V
    Hum Gene Ther; 2011 Jan; 22(1):55-64. PubMed ID: 20653396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptor immunohistochemistry in neuroendocrine tumors: comparison between manual and automated evaluation.
    Kaemmerer D; Athelogou M; Lupp A; Lenhardt I; Schulz S; Luisa P; Hommann M; Prasad V; Binnig G; Baum RP
    Int J Clin Exp Pathol; 2014; 7(8):4971-80. PubMed ID: 25197368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of a
    Radford L; Gallazzi F; Watkinson L; Carmack T; Berendzen A; Lewis MR; Jurisson SS; Papagiannopoulou D; Hennkens HM
    Nucl Med Biol; 2017 Apr; 47():4-9. PubMed ID: 28043006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next Generation of SiFAlin-Based TATE Derivatives for PET Imaging of SSTR-Positive Tumors: Influence of Molecular Design on In Vitro SSTR Binding and In Vivo Pharmacokinetics.
    Litau S; Niedermoser S; Vogler N; Roscher M; Schirrmacher R; Fricker G; Wängler B; Wängler C
    Bioconjug Chem; 2015 Dec; 26(12):2350-9. PubMed ID: 26420336
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.